Clinical Trials Logo

Clinical Trial Summary

This is a prospective, multicenter, non-interventional study. Findings are analyzed using epidemiological methods.


Clinical Trial Description

This NIS shall document the therapy of chronic iron overload in a broad patient population with either of the approved iron chelators in Germany. The choice of patients and the therapy according to the SmPC follows the clinical routine exclusively. The regular observation time per patient is 24 months. Corresponding to the clinical routine, follow up visits can be documented after approximately 1, 3, 6, 9, 12 and 18 month with a close out visit after 24 month. In case the iron chelator is switched, the visit scheme should be passed through once again. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05440487
Study type Observational
Source Novartis
Contact
Status Completed
Phase
Start date September 15, 2015
Completion date October 29, 2021

See also
  Status Clinical Trial Phase
Completed NCT01825512 - Efficacy/Safety Study of Deferiprone Compared to Deferasirox in Paediatric Patients Phase 3
Completed NCT06215287 - Survey to Assess Physicians' Knowledge of Exjade Posology and Biological Monitoring Recommendations as Described in the Educational Materials
Completed NCT01740713 - Pharmacokinetic Study of Deferiprone in Paediatric Patients Phase 2
Completed NCT02720536 - Extended Evaluation of Deferasirox Film-coated Tablet (FCT) Formulation Phase 3